These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11762581)

  • 1. Quebec's $100-million campaign targets meningococcal disease.
    Pinker S
    CMAJ; 2001 Nov; 165(11):1520. PubMed ID: 11762581
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccine coverage survey per cluster sampling after an antimeningococcal mass vaccination campaign at Niamey, Niger in 2000].
    de Chabalier F; Garba A; Chippaux JP
    Sante; 2001; 11(3):173-6. PubMed ID: 11641081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Meningococcal infections in Quebec, 1991-1992].
    Union Med Can; 1992; 121(6):372-3. PubMed ID: 1481298
    [No Abstract]   [Full Text] [Related]  

  • 4. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
    Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE;
    Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of MeNZB vaccination in controlling the New Zealand meningococcal epidemic.
    Lennon D
    N Z Med J; 2008 Mar; 121(1270):110-2. PubMed ID: 18364765
    [No Abstract]   [Full Text] [Related]  

  • 7. Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec.
    De Wals P; Erickson L
    Vaccine; 2002 Jun; 20(21-22):2840-4. PubMed ID: 12102036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mass vaccination against meningococcal disease in three regions of the province of Quebec, January 1992].
    Bouchard F; Banken R; Désilets J; Savard M
    Can J Public Health; 1992; 83(2):131-3. PubMed ID: 1617551
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of serogroup C meningococcal polysaccharide vaccine: results from a case-control study in Quebec.
    De Wals P; Deceuninck G; De Serres G; Boivin JF; Duval B; Remis R; Massé R
    Clin Infect Dis; 2005 Apr; 40(8):1116-22. PubMed ID: 15791510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The first effect of the national vaccination campaign against meningococcal-C disease: a rapid and sharp decrease in the number of patients].
    de Greeff SC; de Melker HE; Spanjaard L; van den Hof S; Dankert J
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1132-5. PubMed ID: 12822525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.
    De Wals P; Coudeville L; Trottier P; Chevat C; Erickson LJ; Nguyen VH
    Vaccine; 2007 Jul; 25(29):5433-40. PubMed ID: 17560695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meningococcal vaccination campaign on a university campus: vaccination rates and factors in nonparticipation.
    Roberts CL; Roome A; Algert CS; Walsh SJ; Kurland M; Lawless K; Cartter ML
    Am J Public Health; 1996 Aug; 86(8):1155-8. PubMed ID: 8712279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Get S.M.A.R.T. about meningitis. School meningitis awareness resource tools: vaccination clinic resource guide.
    Roper JD
    School Nurse News; 2006 Nov; 23(5):38-41. PubMed ID: 17176736
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent trends in meningococcal epidemiology and current vaccine recommendations.
    Baltimore RS
    Curr Opin Pediatr; 2006 Feb; 18(1):58-63. PubMed ID: 16470164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians.
    Kafetzis DA; Stamboulidis KN; Tzanakaki G; Kourea Kremastinou J; Skevaki CL; Konstantopoulos A; Tsolia M
    Clin Microbiol Infect; 2007 May; 13(5):550-2. PubMed ID: 17378929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nursing innovation at the heart of immunisation campaign.
    Manchester A
    Nurs N Z; 2004 Sep; 10(8):10-1. PubMed ID: 15508963
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical inquiries. What are the indications for meningococcal vaccination?
    Moye P; Edgerton L; Flake D; Stephens M
    J Fam Pract; 2007 May; 56(5):396-8. PubMed ID: 17475173
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemiology of meningococcal infection in Kirghizia].
    Zotova AB; Misurenko NK
    Zdravookhr Kirg; 1975; (1):43-7. PubMed ID: 237383
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of the statistical method in the study of meningococcal infectious in Africa south of the Sahara. Applications to epidemiologic and preventive problems].
    Lefevre M; Faucon R
    Med Trop (Mars); 1968; 28(5):640-8. PubMed ID: 5706206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.